Ipratropijev Bromid/Salbutamol Cipla

Ipratropium bromide, the active ingredient in Ipratropijev Bromid/Salbutamol Cipla, is a bronchodilator (anticholinergic + short‑acting β2‑agonist) presented as an inhalation solution for inhalation use. It treats bronchospasm associated with chronic obstructive pulmonary disease (COPD) and asthma.

GNH USA supplies Ipratropijev Bromid/Salbutamol Cipla as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ipratropium bromide/salbutamol is a combined bronchodilator used to relieve airway narrowing in obstructive lung diseases.

- COPD: provides rapid relief of bronchospasm and improves airflow. - Asthma: alleviates acute bronchoconstriction and supports maintenance therapy. - Reversible airway obstruction: helps open airways during acute episodes.

Common Side Effects: - Tremor: mild shaking, often of the hands. - Headache: transient, usually mild. - Throat irritation: discomfort or soreness after inhalation. - Cough: occasional dry cough. - Dry mouth: reduced salivation. - Palpitations: sensation of rapid or irregular heartbeat.

Serious or Rare Side Effects: - Paradoxical bronchospasm: worsening of breathing difficulty. - Cardiac arrhythmia: abnormal heart rhythm, potentially serious. - Angioedema: swelling of face, lips, or throat. - Severe allergic reaction: rash, itching, or anaphylaxis. - Tachycardia: markedly increased heart rate. - Hypokalemia: low blood potassium levels.

Before using this inhalation solution, consider the following precautions: - Cardiac assessment: evaluate for existing heart disease. - Electrolyte monitoring: watch for low potassium, especially with diuretics. - Glaucoma caution: avoid in patients with narrow‑angle glaucoma. - Arrhythmia risk: avoid in severe cardiac arrhythmias. - Hypersensitivity check: do not use if known allergy to either component. - Store at room temperature: keep in original container, protect from moisture and light.

Ipratropium bromide/salbutamol may interact with other medicines. Review the following:

Major Interactions (Avoid): - Beta‑blockers: may diminish bronchodilator effect. - Monoamine oxidase inhibitors: increase risk of cardiovascular side effects. - Diuretics: can exacerbate hypokalemia.

Moderate Interactions (Monitor Closely):\n- Theophylline: may increase risk of tachycardia. - Inhaled corticosteroids: may raise chance of oral thrush. - Other anticholinergics: additive dry‑mouth and urinary retention.